May the odds be ever in your favour? The politics of prognosis
By Joel Michael Reynolds,
Aeon Ideas
| 03. 05. 2018
When I was three years old, I was told that my brother Jason had a 95 per cent chance of dying before he was one. He was born with cerebral palsy, muscular dystrophy and other conditions that made the doctors believe he’d have a dramatically shortened life expectancy. Year after year, my brother outlived this fateful prediction – but its spectre haunted my family and spurred us on in the search for knowledge about Jason’s diagnoses.
All humans naturally desire knowledge, as Aristotle proclaims in the opening line of the Metaphysics. In our present age, one is tempted to add, especially about our health and the health of our loved ones. From Fitbits to WebMD to 23andMe, we commune, conspire and conduct our lives in a thicket of diagnostic and prognostic bioinformation. But, as philosophers from Aristotle to Zhuangzi have insisted, information is meaningless until it is interpreted – and interpretation is always a fraught and messy business.
Jason’s ‘95 per cent’ wasn’t just an indifferent number. My brother’s life is evidence of the politics of probability...
Related Articles
By Alistair Sponsel and Brian Sutton, Springer Nature | 10.05.2026
This essay, co-authored by a historian of science and an X-ray crystallographer, sheds new light on Rosalind Franklin’s Photograph 51. We refute the infamous claim that, unlike James Watson, Franklin failed to see the picture’s potential significance for interpreting the...
By Andrea Martani, BioNews | 10.05.2026
In July 2026, PET and ESHRE published a joint report containing the results of an international survey assessing public attitudes towards the use of embryos in the context of fertility treatment and research. Societal views on these matters are considered...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...